Top Markets
Coin of the day
Sunmax Biotechnology Co., Ltd. Sunmax Biotechnology Co., Ltd.

Sunmax Biotechnology Co., Ltd.

4728
주식 순위 #11504
Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd.... Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd. functions as a biomedical enterprise. The company specializes in the development, manufacturing, and commercialization of collagen-based medical devices across Taiwan and mainland China. Its diverse product line encompasses Porcogen, a sterile, purified collagen solution valuable for medical device applications, tissue engineering, and research. Sunmax also supplies various dermal fillers, including the Sunmax collagen implant series (I-Plus, I) and FACIALGAIN collagen implants (with and without lidocaine), engineered for correcting facial aesthetic concerns such as wrinkles. For dental procedures, they provide specialized collagen-based solutions like Sunmax collagen dental bone grafts, membranes, and granules, used for augmenting or reconstructing the alveolar ridge, extraction sockets, and in periodontics. Additionally, the Sunmax collagen bone graft matrix serves as a bone void filler that naturally resorbs and facilitates new bone formation during recovery. The company's offerings extend to skincare products, such as Sunmax 12 jiao didi spray, Sunmax 11 collagen moisturizing cream, and a general collagen skincare line, all designed for post-dermal filler treatment aftercare.
주가
$12.72
마지막 동기화: 2026-08-27
시가총액
$692.75M
변동 (1일)
0.00%
변동 (1년)
-4.67%
국가
TW
거래 Sunmax Biotechnology Co., Ltd. (4728)

카테고리

Sunmax Biotechnology Co., Ltd. (4728)의 P/B 비율
2026 기준 P/B 비율 TTM: 0
Sunmax Biotechnology Co., Ltd.의 최신 재무 보고서와 주가에 따르면 현재 P/B 비율(TTM)은 0입니다. 2026년 말 기준 P/B 비율은 0였습니다.
Sunmax Biotechnology Co., Ltd.의 P/B 비율 기록 (2026 ~ 2026)
매년 말 P/B 비율
연도 P/B 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/B 비율
회사 P/B 비율 P/B 비율 차이 국가
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH